Latest / Applied Clinical Trials
ACT Brief: CNS Trial Expansion, Vaccine Policy Debate, and New Leadership at FDA
In today’s ACT Brief, we look at what’s fueling rapid growth in CNS and autoimmune research, why former FDA leaders are warning that new vaccine policies could reshape clinical development, and how the agency’s latest leadership change may influence drug review operations.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.